Michelle Hasson's Investing Profile - Galen Partners Venture Partner

Current Investing Position

Galen Partners Venture Partner

Investment Range

$10.0M - $30.0M

Sweet Spot

$20.0M

Current Fund Size

$1B

Michelle Hasson is on these Sector & Stage Rankings

Medical Devices (Seed)Consumer Health (Series B)Pharmaceuticals (Seed)Consumer Health (Series A)Medical Devices (Series B)Medical Devices (Series A)Pharmaceuticals (Series B)Consumer Health (Seed)Pharmaceuticals (Series A)Health & Hospital Services (Series B)Health IT (Series A)New York City Health & Hospital Services (Series A)Boston / New England Digital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Michelle Hasson's Experience

Director, Board of Directors Evolve Treatment Centers2021 - Present

Board Director, Board Of Directors SMP Pharmacy Solutions, a Galen Portfolio Compamy2018 - Present

Special Venture Partner Galen Partners2015 - Present

Hospital Board and VMG Medical Group, Chair, Research committee and Member Strategy Committee Valley Hospital and Health System2014 - Present

Board Director, Board of Directors, a Galen Portfolio Company Easton Associates, LLC (sold to Navigant Consulting in 2012)Present

Hospital Board and VMG Medical Group, Chair, Research committee and Member Strategy Committee Easton Associates, LLC (sold to Navigant Consulting in 2012)Present

Board Director, Board Of Directors Easton Associates, LLC (sold to Navigant Consulting in 2012)Present

Director, Board of Directors Evolve Adolescent Behavioral HealthPresent

Co Founder and CEO MitoMedical2012 - 2020

Board Director, Board of Directors, a Galen Portfolio Company Cambrooke Therapeutics (Aquired by Anjinmoto, Co., Inc.)2012 - 2017

Managing Director and Co-Founder Easton Associates, LLC (sold to Navigant Consulting in 2012)2000 - 2014

Michelle Hasson's Education

Emory University, Yale University